Skip to main content

Advertisement

Log in

Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The epidemiology of primary immune thrombocytopenia (ITP) is not well-characterized in the general population. Most published studies, which have included relatively small numbers of ITP patients, have been conducted in England or Scandinavian countries. No epidemiologic data from Asian countries have been published. This study describes the epidemiology of ITP in a Japanese population. We analyzed the database registry of the Ministry of Health, Labour, and Welfare of Japan, and extracted newly diagnosed acute and chronic ITP patients with a platelet count of <100 × 109/L. From 2004 to 2007, 7,774 cases of ITP were reported, giving an overall incidence of 2.16/100,000/year. The incidence differed greatly between males and females, being 1.72 and 2.58, respectively. The median age of the total affected population was 56 years old. In male patients, there was a striking preponderance of boys below 4 years and a very high peak among those aged 75–89 years. In female patients, the number of ITP patients appeared to show a trimodal distribution by age, with the first peak representing patients below 4 years, the second peak those aged 20–34 years, and the third peak those aged 50–89 years. In conclusion, the incidence of ITP in Japan is not markedly different from that of European countries studied to date. This population-based study reveals that, contrary to previously published studies, the maximum age-specific incidence is in the eighth decade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364–9.

    Article  CAS  PubMed  Google Scholar 

  3. Zaki M, Hassanein AA, Khalil AF. Childhood idiopathic thrombocytopenic purpura: report of 60 cases from Kuwait. J Trop Pediatr. 1990;36:10–3.

    Article  CAS  PubMed  Google Scholar 

  4. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child. 1994;71:251–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997;350:620–3.

    Article  CAS  PubMed  Google Scholar 

  6. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999;94:909–13.

    CAS  PubMed  Google Scholar 

  7. Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K, Wesenberg F. Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol. 2000;17:551–8.

    Article  CAS  PubMed  Google Scholar 

  8. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PRA. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol. 2003;122:966–74.

    Article  PubMed  Google Scholar 

  9. Takahashi I, Yorimitsu S. Epidemiological aspects of idiopathic thrombocytopenic purpura in Kochi prefecture. Jpn J Clin Hematol. 2004;45:372–7. (in Japanese).

    Google Scholar 

  10. Zeller B, Rajantie J, Hedlund-Treutiger I, Tedgård U, Wesenberg F, Jonsson OG, Henter JI. NOPHO ITP. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005;94:178–84.

    Article  PubMed  Google Scholar 

  11. Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol. 2009;145:235–44.

    Article  PubMed  Google Scholar 

  12. Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol. 2009;83:83–9.

    Article  PubMed  Google Scholar 

  13. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3–40.

    CAS  PubMed  Google Scholar 

  14. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnord DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93.

    Article  CAS  PubMed  Google Scholar 

  15. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174–80.

    Article  PubMed  Google Scholar 

  16. Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol. 2004;75:12–7.

    Article  PubMed  Google Scholar 

  17. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Sem Thromb Hemost. 2001;27:253–67.

    Article  CAS  Google Scholar 

  18. Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010;149:855–64.

    Article  PubMed  Google Scholar 

  19. Doan CA, et al. Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med. 1960;53:861–76.

    Article  Google Scholar 

  20. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, editors. Williams hematology. New York: McGraw-Hill; 1995. p. 1315–55.

    Google Scholar 

  21. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a Grant-in Aid for Blood Coagulation Abnormalities from the Ministry of Health, Labour, and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiyuki Kurata.

About this article

Cite this article

Kurata, Y., Fujimura, K., Kuwana, M. et al. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol 93, 329–335 (2011). https://doi.org/10.1007/s12185-011-0791-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0791-1

Keywords

Navigation